Streamline Health® Reports Fiscal First Quarter 2023 Financial Results
12 juin 2023 16h05 HE
|
Streamline Health Solutions, Inc.
First quarter fiscal 2023 SaaS revenue up 12% compared to first quarter fiscal 2022$17.8 million of Booked SaaS ACV as of April 30, 2023 compared to $17.2 million as of January 31, 2023; $12.7...
FSI ANNOUNCES FIRST QUARTER, 2023 FINANCIAL RESULTS
15 mai 2023 16h15 HE
|
Flexible Solutions International, Inc
A Conference call is scheduled for Tuesday May 16th, 2023, 11:00am Eastern Time See dial in number below VICTORIA, BRITISH COLUMBIA, May 15, 2023 (GLOBE NEWSWIRE) -- FLEXIBLE SOLUTIONS...
Palisade Bio Reports First Quarter 2023 Financial Results
12 mai 2023 08h05 HE
|
Palisade Bio, Inc.
Company has sufficient cash expected to fund operations through 2024 Carlsbad, CA, May 12, 2023 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a...
IMUNON Reports First Quarter 2023 Financial Results and Provides Business Update
11 mai 2023 08h00 HE
|
Imunon, Inc.
Non-Viral DNA-Mediated Immunotherapy and Next-Generation Vaccine Programs with Multiple Near-Term Milestones Supported by a Strong Balance Sheet Conference Call Begins Today at 11:00 a.m. EDT...
NEXGEL to Report First Quarter 2023 Financial Results on May 15th
09 mai 2023 09h15 HE
|
NEXGEL, INC.
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider...
Healthier Choices Management Corp. Reports First Quarter 2023 Financial Results
08 mai 2023 08h00 HE
|
Healthier Choices Management Corp
-First Quarter Record Sales of $13.6 Million, Up 169%, over Q1 2022 -First Quarter Record Gross Profit of $4.9M Up 149%, over Q1 2022 HOLLYWOOD, FL, May 08, 2023 (GLOBE NEWSWIRE) --...
IMUNON to Hold First Quarter 2023 Financial Results and Business Update Conference Call on Thursday, May 11, 2023
04 mai 2023 08h30 HE
|
Imunon, Inc.
LAWRENCEVILLE, N.J., May 04, 2023 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing DNA-mediated immunotherapy and next-generation...
MamaMancini’s Reports Fourth Quarter and Fiscal Year 2023 Financial Results
26 avr. 2023 16h05 HE
|
MamaMancini's Holdings, Inc.
Ongoing Margin Enhancement Initiatives Sequentially Grow Gross Margins to 28.2% with $1.8 Million in Net Income in the Fourth Quarter Company Grows Cash Position to $4.4 Million as of January 31,...
AMMO, Inc. Reports Second Quarter 2023 Financial Results
14 nov. 2022 16h05 HE
|
AMMO, Inc.
SCOTTSDALE, Ariz., Nov. 14, 2022 (GLOBE NEWSWIRE) -- AMMO, Inc. (Nasdaq: POWW, POWWP) (“AMMO” or the “Company”), the owner of GunBroker.com, the largest online marketplace serving the firearms and...
PetVivo Reports First Quarter of Fiscal 2023 Financial Results
11 août 2022 16h00 HE
|
PetVivo Holdings, Inc.
Conference call begins at 4:00 p.m. Central time today EDINA, MN, Aug. 11, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the...